Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | HCID 15952274 | HCID 15952274 | — |
| Reactant | HCID 178418573 | HCID 178418573 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 15952275 | HCID 15952275 | 28% |
Reaction Steps
To a solution of 10-[(2′-formyl-1,1′-biphenyl-4-yl)carbonyl]-N-(pyridin-3-ylmethyl)-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide of Example 56 (0.132 g, 0.251 mmol) in dry tetrahydrofuran (15 mL) was added 3.0 Methylmagnesium bromide in diethyl ether (0.68 mL, 2.04 mmol) and the reaction mixture stirred at room temperature under nitrogen for 17 hours. The reaction was quenched by the addition of saturated aqueous ammonium chloride solution (20 mL) and then the mixture partitioned between ethyl acetate (100 mL) and half saturated aqueous ammonium chloride solution (100 mL). The organic phase was separated, washed with brine (100 ml), dried over anhydrous magnesium sulfate, and concentrated in vacuo to afford a cream foam. Purification by flash chromatography using a solvent gradient of 1 to 6% methanol in dichloromethane gave a colorless glass that was triturated with diethyl ether to afford the title compound (0.039 g, 28%) as a white solid, m.p. 111-115° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07678787B2 |
|---|
| Source dataset | uspto-grants-2010_03 |
|---|
| ORD ID | ord-520f7fa2583b4519b533cadc6bdd4d02 |
|---|
| Source note | uspto-grants-2010_03 |
|---|